Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Adhin, Malti R ^a   Labadie Bracho, Mergiory ^b   Vreden, Stephen G ^c  

^a ANTON DE KOM UNIVERSITY OF SURINAME   (Suriname)

^b Institute for Biomedical Sciences   (Suriname)

^c ACADEMIC HOSPITAL PARAMARIBO   (Suriname)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CODON; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PARASITE ISOLATION; PFATP6 GENE; PHENOTYPE; PLASMODIUM FALCIPARUM; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SURINAME;

ARTEMISININS; CALCIUM-TRANSPORTING ATPASES; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MUTATION, MISSENSE; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SURINAME;

EID: 84865955568     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-322     Document Type: Article

References (24)

1. WHO, Position of WHOs Roll Back Malaria Department on Malaria Treatment Policy World Health Organization 2003 www.emro.who.int/RBM/WHOPositionStatement. pdf. 23042461
2. Epidemiology of drug-resistant malaria. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, Lancet Infect Dis 2002 2 209 218 10.1016/S1473-3099(02)00239-6 11937421 (Pubitemid 34464751)
3. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
4. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, Lancet 2012 379 1960 1966 10.1016/S0140-6736(12)60484-X 22484134
5. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Denis MB, Tsuyuoka R, Lim P, Lindegardh N, Yi P, Top SN, Socheat D, Fandeur T, Annerberg A, Christophel EM, Ringwald P, Trop Med Int Health 2006 11 1800 1807 10.1111/j.1365-3156.2006. 01739.x 17176344 (Pubitemid 44813874)
6. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii. Walker DJ, Pitsch JL, Peng MM, Robinson BL, Peters W, Bhisutthibhan J, Meshnick SR, Antimicrob Agents Chemother 2000 44 344 347 10.1128/AAC.44.2.344-347.2000 10639360 (Pubitemid 30060729)
7. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Afonso A, Hunt P, Cheesman S, Alves AC, Cunha CV, Do Rosário V, Cravo P, Antimicrob Agents Chemother 2006 50 480 489 10.1128/AAC.50.2.480-489.2006 16436700 (Pubitemid 43190956)
8. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698 (Pubitemid 41713986)
9. Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections. Pillai DR, Lau R, Khairnar K, Lepore R, Via A, Staines HM, Krishna S, Malar J 2012 11 131 10.1186/1475-2875-11-131 22540925
10. Artemisinins target the SERCA of Plasmodium falciparum. Eckstein-Ludwig U, Webb RJ, van Goethem IDA, East JM, Lee AG, Kimura M, ONeill PM, Bray PG, Ward SA, Krishna S, Nature 2003 424 957 961 10.1038/nature01813 12931192 (Pubitemid 37051688)
11. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Uhlemann A-C, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S, Nat Struct Mol Biol 2005 12 628 629 10.1038/nsmb947 15937493 (Pubitemid 40980816)
12. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, Das D, Phyo AP, Lwin KM, Pukrittayakamee S, Lee SJ, Saisung S, Koecharoen K, Nguon C, Day NPJ, Socheat D, White NJ, Antimicrob Agents Chemother 2010 54 2886 2892 10.1128/AAC.00032-10 20421395
13. WHO, The status of drug-resistant malaria along the Thailand-Myanmar border World Health Organization 2012 http://www.searo.who.int/LinkFiles/ Malaria-drug-resistance-MMMR-THA-border-April-2012.pdf.
14. ABS, Zevende algemene volks- en woningtelling in Suriname: landelijke resultaten volume I, demografische en sociale karakteristieken. Suriname in Cijfers no 213-2005/02. Paramaribo Suriname: Algemeen Bureau voor de Statistiek/Censuskantoor 2005
15. WHO, Report on the situation of malaria in the Americas, 2008 Suriname: World Health Organization Chapter 19 2008 http://new.paho.org/hq/index.php? option=com-content&task=view&id=2459&Itemid=2000.
16. Vreden SGS, Jitan JK, Eersel MGM, Keenswijk WG, Danso T, Bretas G, Ruebush TK, Antimalarial efficacy in Suriname 2001-2006: Implications of evidence-based therapy change http://www.usaidami.org/extras/vreden1.pdf.
17. Rapid and simple method for isolating malaria DNA from fingerprick samples of blood. Foley M, Ranford-Cartwright LC, Babiker HA, Mol Biochem Parasitol 1992 53 241 244 10.1016/0166-6851(92)90026-G 1501643
18. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Snounou G, Beck HP, Parasitol Today 1998 14 462 467 10.1016/S0169-4758(98)01340-4 17040849 (Pubitemid 28539852)
19. Genotypes of merozoite surface protein 2 of Plasmodium falciparum in Tanzania. Felger I, Irion A, Steiger S, Beck HP, Trans R Soc Trop Med Hyg 1999 93 Suppl 1 3 9 10450419 (Pubitemid 29123568)
20. Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCAtype PfATPase6. Ferreira ID, Martinelli A, Rodrigues LA, Do Carmo LE, Do Rosário EV, Pávoa MM, Cravo P, Trop Med Int Health 2008 13 199 207 10.1111/j.1365-3156.2007.01991.x 18304266 (Pubitemid 351316971)
21. Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. Mugittu K, Genton B, Mshinda H, Beck HP, Malar J 2006 5 126 10.1186/1475-2875-5-126 17177997 (Pubitemid 46177993)
22. Resistance to dihydroartemisinin. Cojean S, Hubert V, Le Bras J, Durand R, Emerg Infect Dis 2006 12 1798 1799 10.3201/eid1211.060903 17283645
23. Chloroquine resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt) and multi-drug resistance (mdr1) orthologues involved? Hunt P, Cravo PVL, Donleavy P, Carlton JM-R, Walliker D, Mol Biochem Parasitol 2004 133 27 35 10.1016/j.molbiopara.2003.08.010 14668009 (Pubitemid 37510305)
24. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann A-C, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742 (Pubitemid 39036891)